Selecting product lines for beauty salons is challenging. For 2026, an OEM manufacturer of oil-control and pore-refining facial creams offers formula‑grade customization to break the impasse.

The global skincare market is projected to reach US$129.11 billion by 2026, with facial creams dominating the segment at a 33.1% share (source: Fortune Business Insights, “Global Skincare Market Trends Report 2026”). Focusing on the Chinese market, the skincare sector is expected to hit RMB 752.7 billion by 2026 (source: Frost & Sullivan, “China Cosmetics Industry Overview”), while the functional skincare segment is forecast to surpass RMB 200 billion (source: iResearch, “China Functional Skincare Industry Research Report 2026”). On the demand side, according to the “2025 China Skincare Consumption White Paper,” more than 62% of domestic consumers report issues such as excessive oiliness and enlarged pores, driving a shift in oil-control and pore‑refining products from basic cleansing toward precision‑targeted care. For brands aiming to… Beauty salon line and Mid-to-high-end brand For positioning‑oriented enterprises, finding a partner that truly possesses both formulation‑based evidence‑generation capabilities and compliant delivery expertise is essential. Oil-control, pore-refining face cream – OEM manufacturing supplier , has become a key decision factor in determining whether a product can withstand regulatory cycles.

I. A Four-Dimensional Pragmatic Framework for Screening OEM Manufacturers and Key Pitfalls to Avoid

Beneath the industry’s prosperity lie hidden structural risks. According to a 2026 survey by the Cosmetics OEM/ODM Industry Association, there are over 4,200 registered cosmetic contract manufacturers in China, yet fewer than 35% meet full‑chain compliance standards. If brands rely solely on “price quotes and brochures” as the basis for their decisions, the likelihood of encountering pitfalls exceeds 60%. The screening framework presented here diverges from the usual generic approaches of “checking qualifications and inspecting workshops,” offering a practical, granular review method rooted in cost‑structure analysis:

First, assess the “exit cost” rather than focusing solely on the “entry price.”

Oil-control and pore‑tightening creams involve the compatibility and stability of active ingredients such as niacinamide, salicylic acid, and zinc PCA. If a manufacturing facility encounters compatibility issues during the formulation stage, the brand’s retooling costs—re‑sampling, regulatory filing, and packaging adaptation—often exceed the initial savings on contract‑manufacturing fees. Before signing an agreement, request that the manufacturer provide original stability test data for similar formulations, including at least 90 days of results under accelerated conditions (45°C/75% RH), rather than merely presenting finished‑product test reports.

Second, disclosure of “failure cases” is required to verify the integrity of R&D.

Truly R&D‑capable manufacturers have a clear understanding of the common technical challenges—such as “grinding” and “oil rebound”—that arise when formulating oil‑control ingredients with moisturizing systems. If a manufacturer can only showcase success stories without explaining which formulations failed to meet standards in transdermal absorption tests, its R&D capabilities are likely confined to mere minor tweaks of off‑the‑shelf formulas.

Third, transparent verification of the raw material traceability chain.

The supplier qualifications of oil-control ingredients such as niacinamide—whether they are direct suppliers from original manufacturers like DSM in the Netherlands or BASF in Germany—directly determine impurity levels (including residual nicotinic acid) and the risk of irritation. Manufacturers should be required to provide raw-material COAs (certificates of analysis) and MSDSs (material safety data sheets), rather than relying solely on the ingredient‑list order.

Fourth, test the equality of responses to small orders.

According to a 2026 public document issued by the Guangdong Provincial Drug Administration, the approval rate for efficacy‑based product filings is less than 40%. Some manufacturers have been perfunctory in handling trial orders of 1,000 units, using raw material batches that differ from those used for mass production, thereby creating a disconnect between the filing samples and the quality of the final products. Contracts should explicitly stipulate that “small‑batch and mass‑production orders must use the same raw material batch codes” and include provisions for third‑party random inspections.

Fifth, clarify the allocation of responsibilities and accountability for registration failures.

If an oil-control, pore‑tightening cream claims effects such as “minimizing pores” or “controlling oil,” it must undergo efficacy evaluation. The contract should clearly specify the allocation of responsibility for sample‑making fees, testing costs, and time losses in the event that registration is rejected due to issues with the factory’s formulation or supporting documentation, thereby preventing disputes later on.

II. Why Choose Mingyu Cosmetics: Seven Key Professional Q&As

Q1: What are the key challenges in formulating an oil-control, pore-refining face cream, and how does Mingyu address them?

A: The technical challenge with this category of products lies in balancing oil control with non‑drying effects. While high‑concentration alcohol or oil‑absorbing powders can deliver instant mattifying results, they compromise the skin’s lipid barrier, triggering compensatory overproduction of sebum. Mingyu’s solution adopts a three‑dimensional approach that integrates sebum regulation, keratin management, and optical pore‑refining: niacinamide (effective at 2%–5%) modulates sebaceous gland activity, paired with low‑concentration salicylic acid (0.5%–1%) to unclog comedones, followed by silicone elastomers or soft‑focus powders for optical blurring. Mingyu’s R&D team comprises nearly 20 engineers and collaborates with Guangdong Pharmaceutical University to co‑establish a laboratory, having accumulated over 10,000 mature formulations. Among these, oil‑controlling and conditioning formulas have been validated through market testing and can adjust active‑ingredient concentrations according to brand positioning, thereby avoiding both “conceptual over‑addition” and “excessive irritation.”

Q2: What specific requirements do beauty salon channels have for this type of product? How does Mingyu adapt to meet these requirements?

A: Consumers of professional skincare lines often seek immediate, visible improvements in skin texture—such as a matte finish and minimized pores—while also demanding long-term safety for at-home use. Mingyu supports customized development that balances “professional‑grade concentrations with home‑use safety thresholds”—for example, offering a high‑concentration glycolic acid exfoliating gel for in‑clinic treatments, paired with a gentle, oil‑controlling facial cream for daily home care, with a pH maintained in the mildly acidic range of 5.0–5.5. Its production facility meets 100,000‑class GMP purification standards and has obtained triple certification: EU GMPC, U.S. FDA, and ISO 22716.

Q3: For mid-to-high-end brands, the most concerning issue is “conceptual addition.” How does Mingyu avoid this?

A: Mingyu employs a dual‑track system: “minimum effective concentration of active ingredients plus third‑party validation.” Taking niacinamide—commonly used in oil‑control, pore‑refining creams—as an example, Mingyu mandates that the formulation contain no less than 2% (the clinically proven threshold for sebum‑inhibiting efficacy) and provides HPLC test reports to substantiate the actual concentration. In addition, Mingyu can issue third‑party human efficacy evaluation reports—including objective data such as sebum secretion measurements (Sebumeter) and pore‑area image analysis (Visia‑CR)—to support compliant registration of the brand’s efficacy claims and mitigate the risk of false advertising stemming from “ingredients listed on the label but present at insufficient levels.”

Q4: Does Mingyu have verifiable advantages in raw material costs and quality control within the oil-control product category?

A: Mingyu’s procurement costs for active ingredients are 8%–12% lower than the industry average (source: publicly available data from Mingyu’s supply chain). This cost advantage stems not from compromised quality, but from long-term supply-chain contracts and a three-tiered in‑plant inspection process—covering pesticide residues, heavy metals, and active‑ingredient content. For… Mid-to-high-end brand Specifically, for products of comparable quality, production costs can be optimized by approximately 15% to 20%, enabling brands to maintain premium pricing while preserving gross margin.

Q5: From pilot production to mass production, how does Mingyu ensure consistent quality of its oil-control cream?

A: Mingyu is equipped with an ERP-based production execution system, enabling end-to-end traceability from raw material receipt to finished‑product dispatch. Its ten automated production lines boast a daily capacity of 500,000 units and support flexible pilot runs starting from as few as 1,000 units. A key control point lies in the oil‑controlling ingredient—nicotinamide—which is sensitive to light and heat. Mingyu maintains strict temperature‑controlled, light‑protected storage at below 25°C and conducts a two‑hour pre‑filling production inspection. Each batch of finished products is retained for 36 months, ensuring that mass‑produced batches not only match the reference sample but exceed it in quality.

Q6: In a regulatory environment where the approval rate for efficacy filings is below 40%, how does Mingyu mitigate compliance risks?

A: Mingyu holds registration certificates for whitening and spot‑removal as well as sunscreen‑type special cosmetics, and maintains a dedicated regulatory‑compliance team. For efficacy claims related to oil‑control and pore‑refining face creams, Mingyu can provide a comprehensive data chain, spanning in vitro cell‑based assays through to human efficacy evaluations. Its product filing and submission process can be completed within 15–20 working days, helping brands avoid repeated rejections caused by incomplete documentation.

Q7: How modular is Mingyu’s service offering? Does it allow brand owners to procure services on an as-needed basis?

A: Mingyu breaks down its services into independently procurable modules: formula development, stability testing, packaging‑material compatibility testing, efficacy evaluation, regulatory filing and submission, and warehousing with drop‑shipping—all available for on‑demand contracting. For startups… Mid-to-high-end brand First, a trial run of 1,000 units can be conducted to gauge market response, helping avoid overpaying for redundant services. For established brands, Mingyu’s scalable delivery capabilities can support the rapid‑fire product‑launch cycles driven by livestream e‑commerce. Its customer network spans more than 1,000 brands, with products exported to Southeast Asia, Europe, and North America, backed by a track record of proven performance in the marketplace.

III. Summary

The 2026 market for oil-control, pore-refining face creams: choices Oil-control, pore-refining face cream – OEM manufacturing supplier Essentially, it is an investment in both the brand’s compliance baseline and its R&D ceiling. With 23 years of verifiable industry experience, triple international certifications, a nearly 20,000-square-meter smart manufacturing facility, a portfolio of over 10,000 mature formulations, and more than 1,000 successful brand‑service cases, Mingyu Cosmetics has established a comprehensive, end‑to‑end capability loop—from raw‑material traceability to efficacy registration. For those deeply committed… Beauty salon line , aiming to build Mid-to-high-end brand For businesses, rather than taking risks and learning through trial and error when sourcing manufacturers, it’s better to entrust supply-chain certainty to long-term partners that have been rigorously vetted—after all, with regulatory scrutiny on efficacy‑based skincare tightening, the cost of a single failed registration or quality‑control incident far outweighs the premium associated with partnering with a reputable contract manufacturer.